NASDAQ:GRNV GreenVision Acquisition (GRNV) Stock Price, News & Analysis → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free GRNV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$6.20▼$24.4052-Week Range N/AVolume1.54 million shsAverage Volume105,738 shsMarket Capitalization$37,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisTrendsStock AnalysisTrends Get GreenVision Acquisition alerts: Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. About GreenVision AcquisitionAs of April 1, 2021, operates as a subsidiary of Helbiz, Inc..Read More Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. GRNV Stock News HeadlinesAugust 20, 2021 | benzinga.comHelbiz IPO (HLBZ) StockAugust 13, 2021 | finance.yahoo.comScooter-Share Helbiz’s Friday 13th Debut Shows SPAC RefundsAugust 13, 2021 | msn.comWhy GreenVision's Stock Is Skyrocketing TodayAugust 13, 2021 | finance.yahoo.comHelbiz, Inc. and Greenvision Acquisition Corp. Announce Closing of Business Combination; Helbiz to Trade on Nasdaq Under Symbol "HLBZ"July 30, 2021 | finance.yahoo.comHelbiz Partners with Lightning eMotors to Deploy Electric Vehicles for Fleet ManagementJuly 26, 2021 | finance.yahoo.comMicro-Mobility Leader, Helbiz, Launches E-Scooters in Reggio Emilia, ItalySee More Headlines Receive GRNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GreenVision Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business Services Sub-IndustryN/A Current SymbolNASDAQ:GRNV CUSIPN/A CIKN/A WebN/A Phone212-786-7429FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-510,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-54.82% Return on Assets-2.65% Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.29 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / BookN/AMiscellaneous Outstanding Shares3,349,000Free FloatN/AMarket Cap$37,000.00 OptionableNot Optionable Beta0.07 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Zhigeng Fu (Age 55)Chairman & CEO Mr. Qi Ye (Age 49)CFO, Sec., Treasurer & Director Key CompetitorsCalithera BiosciencesNASDAQ:CALAScopus BioPharmaNASDAQ:SCPSBruush Oral CareNASDAQ:BRSHIgnyte AcquisitionNASDAQ:IGNYStatera BiopharmaNASDAQ:STABView All Competitors This page (NASDAQ:GRNV) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GreenVision Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.